Companies › SUPN

SUPERNUS PHARMACEUTICALS (SUPN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001356576 · EDGAR filings · Updated 2026-07-22

SUPERNUS PHARMACEUTICALS (SUPN) has reported institutional ownership of 100.3%, with 325 institutional managers holding positions valued at $3.01B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (1)

• 2026-07-22 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-22 — Employee-plan registration (S-8) filed
• 2026-06-18 — Current report (8-K) filed
• 2026-05-20 — Current report (8-K) filed
• 2026-05-05 — Quarterly report (10-Q) filed
• 2026-05-05 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SUPERNUS PHARMACEUTICALS has 325 institutional holders and institutional ownership of 100.3%.

Insider activity

Insiders reported 143 transactions (0 buys, 47 sells) across 11 reporting insiders, with a net reported value of −$32.3M.

Data flags from SEC filings

Related companies

ACADIA HEALTHCARE COMPANY IN (ACHC) · HIMS & HERS HEALTH INC (HIMS) · TRAVERE THERAPEUTICS INC (TVTX) · VERACYTE INC (VCYT) · DENALI THERAPEUTICS INC (DNLI) · CARIS LIFE SCIENCES INC (CAI)